Nuclear Medicine: Page 352

Cytogen begins phase III study for Quadramet
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen said that the National Cancer Institute's Radiation Treatment Oncology Group (RTOG) has initiated a randomized phase III trial involving its Quadramet radiopharmaceutical.
July 25, 2006
Alzheimer's Association funds PET scan study
By AuntMinnie.com staff writers
The Alzheimer's Association has awarded a $2.1 million research grant to the Alzheimer's Disease Neuroimaging Initiative (ADNI). The funds will be used to expand the five-year study to include PET scans using Pittsburgh Compound B (PiB), according to the association.
July 23, 2006
IMV reports nuclear medicine growth
By AuntMinnie.com staff writers
U.S. procedure volume in nuclear medicine (excluding PET studies) has been growing at an annualized rate of 5% since 2002, according to a new report published by market research firm IMV Medical Information Division of Des Plaines, IL.
July 23, 2006
FDG-PET successfully diagnoses chronic osteomyelitis
By Jonathan S. Batchelor
FDG-PET has demonstrated great strength in oncology imaging, and is beginning to flex its muscles in infection and inflammation imaging as well. Researchers from Philadelphia have found that FDG-PET is a highly effective imaging method for diagnosing chronic osteomyelitis, a severe and painful infection resulting from bone tissue death due to lost blood supply.
July 20, 2006
Thermo Electron acquires GV Instruments
By AuntMinnie.com staff writers
Medical instrumentation provider Thermo Electron has purchased GV Instruments of Manchester, U.K., a manufacturer of isotope ratio mass spectrometers (IRMS).
July 19, 2006
Schering, Avid partner on Alzheimer's agents
By AuntMinnie.com staff writers
German contrast media firm Schering is partnering with molecular imaging developer Avid Radiopharmaceuticals to develop diagnostic imaging agents for Alzheimer’s disease.
July 16, 2006
Neoprobe to start Lymphoseek trial
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe is starting a phase II clinical study of its Lymphoseek lymphatic tissue targeting agent.
July 12, 2006
NEO expands its physician training program
By AuntMinnie.com staff writers
The Nuclear Education Online (NEO) program has expanded its physician training program to include nuclear education for cardiologists and radiologists.
July 9, 2006
IsoRay pulls Nasdaq application for now
By AuntMinnie.com staff writers
IsoRay has withdrawn its application for a listing on the Nasdaq stock exchange because the Richland, WA, company's stock did not meet the capital market's minimum bid requirement of $4 for more than 10 trading days.
July 6, 2006
IsoRay begins cesium-131 production testing
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical said it has begun production testing the creation of cesium-131 at the Idaho National Laboratory in Idaho Falls.
July 6, 2006
PET trumps MRI for brain cancer chemo response
By Jonathan S. Batchelor
Monitoring the effectiveness of chemotherapy for brain cancer is a critical element in the treatment of the disease. A recent study by French researchers indicates that monitoring chemotherapy efficacy with FDG-PET may detect recurrence of high-grade glioma earlier than imaging studies conducted with MRI.
July 6, 2006
Cardinal scoops up PET radiopharma facilities
By AuntMinnie.com staff writers
Healthcare products firm Cardinal Health has reached an agreement to acquire five PET radiopharmaceutical production facilities, and manage a sixth site.
July 5, 2006
Previous Page
Page 352 of 439
Next Page